<p>Patients and control subjects characteristics with onset of the disease, and other diseases.</p
Clinical and demographic characteristics of case patients and matched controls.</p
Patient and pathogen characteristics of patients with or without an embolic event at any time.</p
Demographic and clinical characteristics of the experimental and control groups at baseline.</p
<p>Sociodemographic and clinical characteristics of the patient and control groups.</p
<p>Patient characteristics associated with each disease phenotype in the training and test sets.</p
<p>Clinical characteristics of the patients according to pathological findings.</p
<p>Clinical characteristics of control and diabetic patients involved in the study.</p
Characteristics of case patients (with neurological complications) and control patients (without neu...
<p>Clinical characteristics of subjects with COPD and healthy control subjects.</p
<p>Characteristics of the patients: matching criteria, concomitant diseases, and medication use.</p
<p>Demographic and clinical characteristics of the patient groups under study.</p
<p>Clinical characteristics of subjects according to the presence of metabolic syndrome.</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
Demographic and clinical characteristics of patients with MDD and healthy controls.</p
<p>Demographic characteristics of the controls and coronary artery disease patients.</p
Clinical and demographic characteristics of case patients and matched controls.</p
Patient and pathogen characteristics of patients with or without an embolic event at any time.</p
Demographic and clinical characteristics of the experimental and control groups at baseline.</p
<p>Sociodemographic and clinical characteristics of the patient and control groups.</p
<p>Patient characteristics associated with each disease phenotype in the training and test sets.</p
<p>Clinical characteristics of the patients according to pathological findings.</p
<p>Clinical characteristics of control and diabetic patients involved in the study.</p
Characteristics of case patients (with neurological complications) and control patients (without neu...
<p>Clinical characteristics of subjects with COPD and healthy control subjects.</p
<p>Characteristics of the patients: matching criteria, concomitant diseases, and medication use.</p
<p>Demographic and clinical characteristics of the patient groups under study.</p
<p>Clinical characteristics of subjects according to the presence of metabolic syndrome.</p
Characteristics of the major clinical subgroups and their healthy control counterparts.</p
Demographic and clinical characteristics of patients with MDD and healthy controls.</p
<p>Demographic characteristics of the controls and coronary artery disease patients.</p
Clinical and demographic characteristics of case patients and matched controls.</p
Patient and pathogen characteristics of patients with or without an embolic event at any time.</p
Demographic and clinical characteristics of the experimental and control groups at baseline.</p
DOI
Add to ORKG